SIU 2017: Robotic Partial Nephrectomy for Complex Renal Lesions: Strategies for Success - A Multi-institutional Study

Lisbon, Portugal (UroToday.com) Due to their size, location and proximity to the hilum, some complex renal tumors may preclude a minimally invasive approach to nephron sparing surgery. The authors describe their technique of robotic partial nephrectomy for challenging complex renal tumors.

This is a study of 249 patients who underwent robotic partial nephrectomy (RPN) in multiple institutions. Patients were identified using a prospective RPN databases. A complex renal lesion was defined as a tumor with a RENAL nephrometry score > 10. 

Thirty-one (12.4%) of RPN were for complex renal tumors. Median age was 57 (50.5 - 70.5) years. Twenty-one (67.7%) were male, 10 (32.3%) were female. American Society of Anesthesiologists score was 2 (2 -3). Median operative time was 200 (50 - 265) min, median warm ischemia time was 23 (18.5-29) min, and median blood loss was 200 (50 - 265) ml. There were no intraoperative complications, but 2 (6.4%) of patients had post-operative complications. 1 (3.2%) patient had a positive margin. Length of stay was 3.5 (3-5) days. Median follow up was 12.5 (7 - 24) months, and there were no recurrences. RPN did result in statistical significant changes in renal function 3 months post RPN compared to preoperative renal function, p=0.0001.

The authors conclude that RPN is a safe approach for select patients with complex renal tumors, and may facilitate tumor resection and renorrhaphy for challenging cases.


Presented by: Derek Hennessey
Affiliation:  Dept. of Surgery, Austin Health, The University of Melbourne, Australia

Written by: Hanan Goldberg, MD, Urologic Oncology Fellow (SUO), University of Toronto, Princess Margaret Cancer Centre.Twitter: @GoldbergHanan at the 37th Congress of Société Internationale d’Urologie - October 19-22, 2017- Lisbon, Portugal




E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe